Glucosylated nanoparticles for the oral delivery of antibiotics to the proximal small intestine protect mice from gut dysbiosis
- 7 July 2022
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 6 (7) , 867-881
Abstract
Orally delivered antibiotics can reach the caecum and colon, and induce gut dysbiosis. Here we show that the encapsulation of antibiotics in orally administered positively charged polymeric nanoparticles with a glucosylated surface enhances absorption by the proximal small intestine through specific interactions of glucose and the abundantly expressed sodium-dependent glucose transporter 1. This improves bioavailability of the antibiotics, and limits their exposure to flora in the large intestine and their accumulation in caecal and faecal contents. Compared with the standard administration of the same antibiotics, the oral administration of nanoparticle-encapsulated ampicillin, chloramphenicol or vancomycin in mice with bacterial infections in the lungs effectively eliminated the infections, decreased adverse effects on the intestinal microbiota by protecting the animals from dysbiosis-associated metabolic syndromes and from opportunistic pathogen infections, and reduced the accumulation of known antibiotic-resistance genes in commensal bacteria. Glucosylated nanocarriers may be suitable for the oral delivery of other drugs causing gut dysbiosis.Keywords
Funding Information
- National Natural Science Foundation of China (51903105, 52025036, 81822021, 82061148013, 91842105, 31770990, 81821001)
This publication has 43 references indexed in Scilit:
- Antibiotic Administration Routes Significantly Influence the Levels of Antibiotic Resistance in Gut MicrobiotaAntimicrobial Agents and Chemotherapy, 2013
- Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile InfectionAntimicrobial Agents and Chemotherapy, 2013
- Antibiotics in early life alter the murine colonic microbiome and adiposityNature, 2012
- Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced ColitisInfection and Immunity, 2012
- Antibiotic Treatment Alters the Colonic Mucus Layer and Predisposes the Host to Exacerbated Citrobacter rodentium -Induced ColitisInfection and Immunity, 2011
- Pharmacokinetics and Pharmacodynamics of Antibacterial AgentsInfectious Disease Clinics of North America, 2009
- Quantitative PCR Monitoring of Antibiotic Resistance Genes and Bacterial Pathogens in Three European Artificial Groundwater Recharge SystemsApplied and Environmental Microbiology, 2009
- Targeting bile-acid signalling for metabolic diseasesNature Reviews Drug Discovery, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005